Skip to main content
Cartesian Therapeutics, Inc. logo

Cartesian Therapeutics, Inc. — Investor Relations & Filings

Ticker · RNAC ISIN · US8162121045 US Manufacturing
Open in API
Filings indexed 854 across all filing types
Latest filing 2026-06-09 Regulatory Filings
Country US United States of America
Listing US RNAC

About Cartesian Therapeutics, Inc.

https://www.cartesiantherapeutics.com/

Cartesian Therapeutics, Inc. is a clinical-stage company that pioneers the development of mRNA-engineered cell therapies. The company's primary focus is on creating treatments for autoimmune diseases. Leveraging its novel mRNA technology platform, Cartesian develops therapeutic cells designed to target the drivers of these conditions. This approach aims to expand the reach and potential of cell therapy for patients with various autoimmune disorders. The company's lead asset, Descartes-08, is a central component of its clinical pipeline.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings Classification · 88% confidence The document is a Current Report on Form 8-K filed with the SEC under the Exchange Act, disclosing a Regulation FD press release about a strategic licensing agreement. It is not itself a financial statement (10-K, IR) nor an investor presentation or earnings release, but a routine regulatory announcement via Form 8-K, Item 7.01. It has no substantive financial tables or management changes, and instead provides an attached press release. Therefore, it falls under the general Regulatory Filings category (RNS).
2026-06-09 English
8-K
Capital/Financing Update Classification · 85% confidence The document is a Form 8-K current report primarily detailing Cartesian’s entry into a Loan and Security Agreement providing for senior secured term loans of up to $150 million, including tranche amounts, interest rates, covenants, and conversion features. This constitutes an update on the company’s financing activities. Therefore, it falls under Capital/Financing Update (CAP).
2026-05-26 English
S-8 - Cartesian Therapeutics, Inc. (0001453687) (Filer)
Share Issue/Capital Change Classification · 100% confidence The document is a Form S-8 Registration Statement filed with the SEC, which is used to register securities to be offered under employee benefit plans such as incentive award plans. It includes details about the registration of additional shares under the company's Amended and Restated 2016 Incentive Award Plan. The document references incorporation by reference of other filings but itself is a registration statement related to share issuance under an employee plan. This type of filing is related to capital changes and share issuance rather than financial performance reports, management changes, or other categories. Therefore, the appropriate classification is Share Issue/Capital Change (SHA). The document length and content confirm it is the actual registration statement, not just an announcement or certification.
2026-04-30 English
10-Q - Cartesian Therapeutics, Inc. (0001453687) (Filer)
Interim / Quarterly Report
2026-04-30 English
8-K - Cartesian Therapeutics, Inc. (0001453687) (Filer)
Earnings Release Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated April 30, 2026. It announces the financial results for the quarter ended March 31, 2026, and includes a press release as Exhibit 99.1. The text explicitly states that the information is furnished as a press release and is not deemed filed for certain regulatory purposes. The document length is 3568 characters, which is relatively short and consistent with a current report rather than a full quarterly report. The content corresponds to an initial announcement of quarterly financial results, which matches the definition of an Earnings Release (ER).
2026-04-30 English
DEF 14A - Cartesian Therapeutics, Inc. (0001453687) (Filer)
Proxy Solicitation & Information Statement
2026-04-28 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.